Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis-Reference-Cited by-同舟云学术

Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis

Published:2018-01-31 Issue:1 Volume:8 Page:
ISSN:2110-5820
Container-title:Annals of Intensive Care
language:en
Short-container-title:Ann. Intensive Care

Author:

Annane Djillali,Mira Jean-Paul,Ware Lorraine B.,Gordon Anthony C.,Hinds Charles J.,Christiani David C.,Sevransky Jonathan,Barnes Kathleen,Buchman Timothy G.,Heagerty Patrick J.,Balshaw Robert,Lesnikova Nadia,de Nobrega Karen,Wellman Hugh F.,Neira Mauricio,Mancini Alexandra D. J.,Walley Keith R.,Russell James A.

Funder

SIRIUS GENOMICS INC

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

http://link.springer.com/article/10.1186/s13613-018-0353-2/fulltext.html

Reference16 articles.

1. Wang L, McLeod HL, Weinshilboum RM. Genomics and drug response. N Engl J Med. 2011;364(12):1144–53.

2. Schwarz UI, Ritchie MD, Bradford Y, et al. Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med. 2008;358(10):999–1008.

3. Rieder MJ, Reiner AP, Gage BF, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med. 2005;352(22):2285–93.

4. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344(10):699–709.

5. Abraham E, Laterre PF, Garg R, et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med. 2005;353(13):1332–41.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers in Critical Care Illness: ARDS and Sepsis;Precision in Pulmonary, Critical Care, and Sleep Medicine;2020

2. How have genomics informed our understanding of critical illness?;Evidence-Based Practice of Critical Care;2020